demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 (hospitalized or not)
Immunostimulants drugs
levamisole Roostaei
neutralizing antibody
casirivimab/imdevimab (Ronapreve) Wei

5 studies excluded by filtering options 2

5405 Ahn, 2020 200excludedrisk of bias not avaialble
5408 Shen, 2020 200excludedrisk of bias not avaialble
5409 Ye, 2020 200excludedrisk of bias not avaialble
5410 Zhang, 2020 200excludedrisk of bias not avaialble
5411 Zhang, 2020 200excludedrisk of bias not avaialble